Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster dose
Latest Information Update: 06 Sep 2023
At a glance
- Drugs AZD 1222 (Primary) ; SARS-COV-2 vaccine-inactivated-Sinovac-Biotech (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections; SARS-CoV-2 acute respiratory disease
- Focus Pharmacodynamics
Most Recent Events
- 06 Sep 2023 New trial record